4/A//SEC Filing
Wang David 4/A
Accession 0001437749-12-006304
CIK 0000806888other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 8:10 PM ET
Size
5.4 KB
Accession
0001437749-12-006304
Insider Transaction Report
Form 4/AAmended
Wang David
Director
Transactions
- Award
Stock Option (Right to Buy)
2012-04-02+400,000→ 400,000 totalExercise: $0.11Exp: 2022-04-02→ Common Stock (400,000 underlying)
Footnotes (3)
- [F1]Exercise prices shown are denominated in Canadian dollars.
- [F2]100% of the options vest fully on the date which is one year after the date of grant.
- [F3]The options granted were subject to approval of shareholders and the Toronto Stock Exchange. Shareholders approval was obtained on June 19, 2012.
Documents
Issuer
RESPONSE BIOMEDICAL CORP
CIK 0000806888
Entity typeother
Related Parties
1- filerCIK 0001539099
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 8:10 PM ET
- Size
- 5.4 KB